PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis (PICASO)

NCT07256197 PHASE3 NOT_YET_RECRUITING

Calcific aortic stenosis (CAS) can cause severe adverse cardiac events, but there are currently no effective drugs that can prevent or delay the progression of the disease. Our trial aims to investigate the effect of PCSK9 inhibitors on preventing or delaying the progression of CAS.

Details

Lead sponsor	Beijing Anzhen Hospital
Phase	PHASE3
Status	NOT_YET_RECRUITING
Enrolment	160
Start date	Wed Apr 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Jan 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Aortic Stenosis, Calcific

Interventions

• Treatment with PCSK9 inhibitors
• Treatment without PCSK9 inhibitors

Countries

China